Generic drugmaker Viatris has sued Danish pharmaceutical giant Novo Nordisk in Delaware ​federal court, seeking a ruling that ...

Viatris subsidiary Mylan Pharmaceuticals has sued Danish drugmaker Novo Nordisk in a federal court in Delaware, seeking a ruling that its planned generic version of the weight-loss drug Wegovy does ...

By moving early, Mylan hopes to clear regulatory and intellectual-property hurdles before a generic can reach the market. The ...

Shares of Mylan N.V. (NASDAQ: MYL) are soaring today, up 16.4% as of 11:40 a.m. EST, after the drugmaker reported better-than-expected Q3 earnings following the market close on Monday. Mylan announced ...

Shares of Mylan (NASDAQ: MYL) were sinking 11.4% as of 11:09 a.m. EST on Wednesday. The drugmaker reported its fourth-quarter results after the market closed on Tuesday. Unfortunately, there was very ...

MYL (MYL) stock news, price prediction, earnings and analysis from 24/7 Wall St.

Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...

Comprehensive report includes a look at Mylan's historical impact on patients, employees, the environment, global public health and the community HERTFORDSHIRE, England and PITTSBURGH, May 4, 2020 ...

Mylan said last month it would restart production of hydroxychloroquine to meet global demand. (Mylan) Mylan is one of a group of drugmakers that have joined the global effort to supply doses of ...

Mylan, a company best known for generic drugs, watched its stock slide last year after it was named along with other generic-drug manufacturers in a case alleging price-fixing. The lawsuit, brought by ...

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its more "consumer-friendly ...